The effect of narrowband ultraviolet B on the expression of matrix metalloproteinase-1, transforming growth factor-β1 and type I collagen in human skin fibroblasts

Clinical and Experimental Dermatology

Volumn 32, Issue 2, 2007, Pages 180-185

  Choi, C P ^a   Kim, Y I ^a   Lee, J W ^a   Lee, M H ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PHOTOAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; ULTRAVIOLET B RADIATION; WESTERN BLOTTING;

CELLS, CULTURED; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; INFANT, NEWBORN; MATRIX METALLOPROTEINASE 1; SKIN; TRANSFORMING GROWTH FACTOR BETA1; ULTRAVIOLET RAYS;

EID: 33846927808     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02309.x     Document Type: Article

References (14)

1. Fisher GJ, Datta SC, Talwar HS et al. Molecular basis of sun-induced premature skin aging and retinoid antagonism. Nature 1996; 379: 335-9.
2. Thomson BM, Atkinson SJ, McGarrity AM et al. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade. Biochim Biophys Acta 1989; 1014: 125-32.
3. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-45.
4. Edwards DR, Murphy G, Reynolds JJ et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-904.
5. El-Ghorr AA, Norval M. Biological effects of narrow-band (311-nm TL01) UVB irradiation: a review. J Photochem Photobiol 1997; 38: 99-106.
6. British Photodermatology Group. An appraisal of narrow band (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997; 137: 327-30.
7. Wiskemann A. UVB-Phototherapie der Psoriasis mit einer fur die PUVA-Therapie entwickelten Stehbox. Z Hautkr 1978; 53: 633-6.
8. van Weelden H, De La Faille HB, Young E et al. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
9. Green C, Ferguson J, Lakshmipathi T et al. 311-nm UVB phototherapy-an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-6.
10. Serish Srinivas CR. Minimal erythema dose to narrow band ultraviolet-B broad band ultraviolet-B-A pilot study. Indian J Dermatol Venereol Leprol 2002; 68: 63-4.
11. Slaper H, Schothorst AA, Van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology 1986; 3: 271-83.
12. Smith JG Jr, Davidson EA, Sams WM Jr et al. Alterations in human dermal connective tissue with age and chronic sun damage. J Invest Dermatol 1962; 39: 47-350.
13. West MD. The cellular and molecular biology of skin aging. Arch Dermatol 1994; 130: 87-95.
14. Meikle MC, McGarrity AM, Thomson BM et al. Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts. Bone Miner 1991; 12: 41-55.